A Multicenter, Randomized, Double-Blind, Risankizumab-Controlled, Parallel-Group Study To Evaluate The Efficacy And Safety Of Bimekizumab In Adult Study Participants With Active Psoriatic Arthritis

  • Antony, Anna (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date13/02/25 → 12/02/30